批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/02/21 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/07/20 |
SUPPL-42(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/10/03 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/30 |
SUPPL-37(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2013/06/04 |
SUPPL-36(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/02/15 |
SUPPL-35(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/01/11 |
SUPPL-34(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/01/24 |
SUPPL-33(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2011/07/29 |
SUPPL-30(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2009/07/21 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/07/21 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/01/27 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2008/06/05 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/06/05 |
SUPPL-20(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2008/02/07 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/12/10 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/12/10 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2006/11/02 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/05/23 |
SUPPL-13(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2006/03/16 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/03/16 |
SUPPL-12(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2006/01/19 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/03/22 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/03/02 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/09/22 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/07/23 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/07/23 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/07/23 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/10/25 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:EZETIMIBE 剂型/给药途径:TABLET;ORAL 规格:10MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021445 |
001 |
NDA |
ZETIA |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
Yes |
Yes |
AB |
2002/10/25
|
ORGANON |
078560 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2015/06/26
|
GLENMARK PHARMS LTD |
200831 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2017/06/12
|
WATSON LABS INC |
203931 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2017/06/12
|
SANDOZ |
204331 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2017/06/12
|
ZYDUS PHARMS |
207311 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2017/06/12
|
OHM LABS INC |
208803 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2017/06/12
|
AMNEAL PHARMS CO |
209838 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2017/08/25
|
AUROBINDO PHARMA |
209234 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2017/12/21
|
ALKEM LABS LTD |
211550 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2018/10/26
|
ACCORD HLTHCARE |
210673 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2020/10/23
|
SCIEGEN PHARMS INC |
210859 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2022/07/26
|
HETERO LABS LTD III |
215693 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2022/09/13
|
ORIENT PHARMA |
211159 |
001 |
ANDA |
EZETIMIBE |
EZETIMIBE |
TABLET;ORAL |
10MG |
Prescription |
No |
No |
AB |
2024/04/29
|
MACLEODS PHARMS LTD |